NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011
Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009
Health-related quality of life (HRQL) and use of formoterol in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001
A comparative trial of tiotropium, salmeterol and placebo: health-related quality of life Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001
Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Health-related quality of life (HRQL) and patient-reported outcomes (PRO) in COPD patients receiving add-on-therapy with EPs® 7630 Source: Annual Congress 2011 - COPD management Year: 2011
Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001
Determinants of health-related quality of life (HRQL) in patients with COPD Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008
Single inhaler triple therapy in patients with COPD: response rates in health-related quality of life in the IMPACT Trial Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018
Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts) Source: Annual Congress 2011 - COPD management Year: 2011
Budesonide/formoterol adjustable maintenance dosing (AMD) improves health-related quality of life (HRQL) compared with high-dose budesonide (AMD) Source: Eur Respir J 2004; 24: Suppl. 48, 311s Year: 2004
The association between health-related quality of life and COPD exacerbations measured by EQ-5D-5L in the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Effect of a self-management programme on health-related quality of life in COPD patients: a randomised controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 377s Year: 2002
Quality of life and symptoms improvement after 6 months treatment with roflumilast 500 μg daily in a large Greek COPD cohort Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
A placebo controlled trial with inhaled mannitol improves health related quality of life in patients with bronchiectasis Source: Annual Congress 2004 - Bronchiectasis Year: 2004
The effect of COPD and FEV1 decline on health-related quality of life: A longitudinal, population-based study Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Health-related quality of life in women outpatients with COPD in daily practice Source: Eur Respir J 2007; 30: Suppl. 51, 631s Year: 2007
TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting. Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
What predicts a deterioration of generic and disease-specific health-related quality of life in COPD? First longitudinal results of the COSYCONET cohort Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017